NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) - ANVISA Registration 10033120643

Access comprehensive regulatory information for NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10033120643 and manufactured by manufacturer not specified. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Nov 30, 2025.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10033120643
2 Related Devices
Registration Details
ANVISA Registration Number: 10033120643
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10033120643

25351265823200923

42160812000144

Dates and Status

Nov 30, 2010

30/11/2025

09/18/2025 19:00:01

Registration Details

10033120643

25351265823200923

42160812000144

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Nov 30, 2010

30/11/2025

09/18/2025 19:00:01